| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $106K | +492.6% | -14.5% |
| SG&A Expense | $1.9M | +35.6% | +65.1% |
| Operating Income | -$1.4M | +15.1% | -12.7% |
| Interest Expense | $342K | — | +1122.3% |
| Pre-tax Income | -$2.0M | -20.9% | -13.4% |
| Income Tax | $35 | — | +101.6% |
| Net Income | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.8M | — | +9890.2% |
| Current Assets | $43.5M | +997.5% | +1779.3% |
| Total Assets | $43.5M | +997.0% | +1779.4% |
| Current Liabilities | $4.9M | -12.3% | +10.5% |
| Stockholders' Equity | $38.5M | +2433.0% | +1900.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.8M | — | — |
| Investing Cash Flow | -$1.8M | — | — |
| Financing Cash Flow | $44.2M | — | — |
| -13.6% |
| EPS (Basic) | -$4.68 | -368.0% | +0.4% |
| EPS (Diluted) | -$4.68 | -368.0% | +0.4% |